Skip to main content
Sanofi
Healthcare · Drug Manufacturers - General
Made on Jul 24, 2026
Price at call $43.36
6-month call Bear -11.2%
Target by Jan 2027 $38.50
Great value below $37.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -11.2% to $38.50
Predicted High $43.10 in 2 weeks
Predicted Low $38.50 at 6 months
Max Drawdown (predicted) -11.2%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Jul 24, 2026 9:02 am
Bear SNY trends lower to $38.50 (-11.2% from $43.36) by Jan 2027. decay
ThesisSNY trades above composite fair value ($34.56) with a neutral-to-negative sentiment backdrop, GLP-1/biosimilar overhangs, and no near-term earnings catalyst. Low beta and defensive characteristics limit downside velocity, so expect a slow drift toward fair value rather than a sharp repricing, with mild stabilization as the stock approaches the mid-$30s.
Invalidated ifA break above $46 on positive pipeline/M&A news, or a break below $38 on a broad risk-off cascade, invalidates the slow-drift thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $43.36 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Jul 24, 2026 — $43.36 at call — —The anchor — every point below is measured from this price and date.
2 weeks Aug 7, 2026 $40.99–$45.73 typical range · internal point $43.10 — ±5.5% 6/10 Risk-off regime, low beta cushions near-term drift
What actually happened: closed $42.89 on Aug 6, 2026 = -1.1% vs the call (predicted -0.6%)  ·  direction HIT (called flat, was flat)  ·  off by 0.5 pp  ·  accuracy 10/10  ·  typical range ±5.5%: inside the band  ·  S&P +4.0% over the same window — beat it
1 month Aug 24, 2026 $39.92–$46.80 typical range · internal point $42.60 — ±7.9% 6/10 No catalyst, mild mean reversion toward baseline
What actually happened: closed $45.85 on Aug 21, 2026 = +5.7% vs the call (predicted -1.8%)  ·  direction MISS (called flat, was up)  ·  off by 7.5 pp  ·  accuracy 4/10  ·  typical range ±7.9%: inside the band  ·  S&P +3.5% over the same window — lagged it
2 months Sep 24, 2026 $41.80 — -3.6% 5/10 Value gravity begins pulling toward fair value
What actually happened: closed $41.66 on Sep 23, 2026 = -3.9% vs the call (predicted -3.6%)  ·  direction HIT (called flat, was flat)  ·  off by 0.3 pp  ·  accuracy 10/10  ·  S&P +4.0% over the same window — beat it
3 months Oct 24, 2026 $40.90 — -5.7% 5/10 Q3 print risk, biosimilar narrative pressure
4 months Nov 24, 2026 $39.80 — -8.2% 4/10 Continued drift as overvaluation gap compresses
5 months Dec 24, 2026 $38.90 — -10.3% 4/10 Approaching attractive zone, buyers emerge below $39
6 months Jan 24, 2027 $38.50 — -11.2% 4/10 Stabilization near value anchor, defensive bid holds

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $42.21 (-2.6%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 0 degraded · 2 notes — follow the chain top-down (cause → effect).
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$43.36
Composite fair value$34.56
Signal-adjusted fair value$34.56
DCF fair value—
Anchored-PE fair value—
Buy-below (value lens)$37.00
Value net score-53
Value confidence6 / 10
Quality net score+34
Memo confidence7 / 10
Deserved value (base)—
Quality tilt—
Deserved value (used)—
Coherence (value × quality)—

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 25.4%  3m 27.5%  6m 25.4%  
Daily σ (realism noise)1.7%
Beta vs S&P 500 1m -0.14  3m 0.28  5m 0.36  
Trailing 6-month return-6.1%

Knobs (equation params)

ladder["w2","m1","m2","m3","m4","m5","m6"]
llm_modelclaude-opus-4-7
max_tokens3000
control_knobs{"w_dcf":0.5,"k_qual":0.200000000000000011102230246251565404236316680908203125,"reach_6m":0.450000000000000011102230246251565404236316680908203125,"coh_floor":0.5,"conf_gain":0.059999999999999997779553950749686919152736663818359375,"noise_phi":0.84999999999999997779553950749686919152736663818359375,"conf_floor":0.40000000000000002220446049250313080847263336181640625,"w_composite":0.5,"noise_window":"3m","flat_band_pct":5,"horizon_months":6,"noise_sigma_fallback":0.01499999999999999944488848768742172978818416595458984375}
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 8, 2026 15d behind SNY-20260708-030001-27e5
ext-forensic-memo Jul 23, 2026 freshest ext-SNY-20260723-130921-c89b
ext-lens-quality Jul 23, 2026 freshest ext-SNY-20260723-130921-c89b
ext-lens-sentiment Jul 23, 2026 freshest ext-SNY-20260723-130921-c89b
ext-lens-value Jul 23, 2026 freshest ext-SNY-20260723-130921-c89b
scenario-valuation Jul 23, 2026 freshest SNY-20260723-124200-4c25
valuation-synthesis Jul 23, 2026 freshest SNY-20260723-124200-4c25

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

4 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 1, 2026 v0.6.0 Bull $43.08 $51.25 +19.0% Feb 2027 view
Jul 25, 2026 v0.6.0 Bull $43.36 $47.80 +10.2% Jan 2027 view
Jul 24, 2026 v0.6.0 Bear $43.36 $38.50 -11.2% Jan 2027 viewing
Jul 8, 2026 v0.3.0 Bull $42.98 $60.11 +39.9% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.